Esco Lifesciences completed the spin-off of Esco Aster.

Synopsis

Esco Lifesciences, a life science company, completed the spin-off of Esco Aster, a vertically-integrated contract research organization. Financial terms were not disclosed.

Principals

target

Esco Aster

bidder

Institutional Investors

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

davis polk & wardwell

HQ - New York

legal advisors

vendor

1186

Deals

£ 2,482.31 B

Total Value